Prot #104-201506: A Prospective, Randomized, Double Blind, Placebo-Controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere’s Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date4/20/164/20/19

Funding

  • Otonomy, Inc. (Prot #104-201506)